Markets:

Overview

News

Currencies

International

Treasuries

Maravai LifeSciences Holdings, Inc. - Class A common stock (NQ:MRVI)

7.235 +1.495 (+26.05%)

Streaming Delayed Price Updated: 3:02 PM EDT, Aug 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Maravai LifeSciences Holdings, Inc. - Class A common stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

This Analyst With 85% Accuracy Rate Sees Over 29% Upside In NVIDIA - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts ↗

February 27, 2023

US stocks closed lower on Friday, with the Dow Jones dropping more than 300 points during the session.

Via Benzinga

The Latest Analyst Ratings for Maravai LifeSciences ↗

February 24, 2023

Via Benzinga

Why Domino's Pizza Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

February 23, 2023

Gainers

Via Benzinga

Earnings Outlook For Maravai LifeSciences ↗

February 21, 2023

Via Benzinga

5 Value Stocks In The Healthcare Sector ↗

January 30, 2023

Via Benzinga

Where Maravai LifeSciences Stands With Analysts ↗

December 07, 2022

Via Benzinga

6 Analysts Have This to Say About Maravai LifeSciences ↗

December 07, 2022

Via Benzinga

Comfort Systems, Gannett, CommScope And Other Big Stocks Moving Higher On Thursday ↗

February 23, 2023

U.S. stocks traded slightly lower, with the Dow Jones dropping around 30 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Maravai LifeSciences (MRVI) Q4 2022 Earnings Call Transcript ↗

February 23, 2023

MRVI earnings call for the period ending December 31, 2022.

Via The Motley Fool

Maravai LifeSciences Reports Fourth Quarter and Full Year 2022 Financial Results

February 22, 2023

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

2 Healthcare Companies That Could Be Acquired Within 5 Years ↗

February 07, 2023

These stocks are also cheap buys that are down more than 60% from their highs.

Via The Motley Fool

Where Maravai LifeSciences Stands With Analysts ↗

November 04, 2022

Analysts have provided the following ratings for Maravai LifeSciences (NASDAQ:MRVI) within the last quarter:

Via Benzinga

Analyst Ratings for Maravai LifeSciences ↗

November 03, 2022

Analysts have provided the following ratings for Maravai LifeSciences (NASDAQ:MRVI) within the last quarter:

Via Benzinga

Earnings Scheduled For February 22, 2023 ↗

February 22, 2023

Companies Reporting Before The Bell • Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022.

Via Benzinga

Catalent Hits Four-Month High As Danaher Reportedly Mulls A Takeover ↗

February 06, 2023

Danaher is reportedly looking to add to its wheelhouse to compete with Thermo.

Via Investor's Business Daily

Maravai LifeSciences to Host Earnings Conference Call on Wednesday, February 22, 2023

February 01, 2023

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

3 Great Growth Stocks Down 20% or More to Buy Now ↗

January 27, 2023

These beaten-down stocks could be poised for major rebounds.

Via The Motley Fool

3 Biopharma Stocks That Could Help Make You a Fortune ↗

January 16, 2023

All three are protected by sales of in-demand products, with more on the way.

Via The Motley Fool

Maravai LifeSciences Announces Updated CEO Leadership Transition Plans

December 01, 2022

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023 ↗

January 05, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022 ↗

December 14, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

December 08, 2022

During Thursday's trading, 138 companies set new 52-week lows.

Via Benzinga

2 Biotech Stocks You Can Buy and Hold for the Next Decade ↗

November 28, 2022

These two companies are facing short-term issues that are likely to give way to long-term success.

Via The Motley Fool

Maravai LifeSciences Named to the 2022 Deloitte Technology Fast 500™ List of Fastest-Growing Companies in North America

November 16, 2022

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

New Kit Predicts Retroviral Particle Clearance in Biopharmaceutical Manufacturing

November 07, 2022

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

What 6 Analyst Ratings Have To Say About Maravai LifeSciences ↗

November 04, 2022

Within the last quarter, Maravai LifeSciences (NASDAQ:MRVI) has observed the following analyst ratings:

Via Benzinga

Maravai LifeSciences Announces November and December 2022 Investor Conference Schedule

November 03, 2022

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

November 03, 2022

We're starting off the day with a look at the latest news behind the biggest pre-market stock movers for Thursday morning!

Via InvestorPlace

Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2022 Earnings Call Transcript ↗

November 03, 2022

MRVI earnings call for the period ending September 30, 2022.

Via The Motley Fool

Maravai LifeSciences Reports Third Quarter 2022 Financial Results

November 02, 2022

Updates Revenue, Adjusted EBITDA and Adjusted EPS Guidance for 2022

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.